Q&A

Comprehensive Clinical Supply Strategies For Compressed Timeline Trials

Source: Catalent
gettyimages-1302454451-170667a

Drug developers have numerous issues to consider when compressing timelines for clinical studies, from ensuring sufficient study materials will reach the clinic on time, to upholding the integrity of the study. In this Q&A, Gavin Yates, Program Director, CSS and Drug Product Technologies Integrations at Catalent, discusses strategies for mitigating risks and addressing challenges encountered during clinical studies with compressed timelines.

VIEW THE Q&A!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader